Axcella Addresses Metabolic Disease Quickly With GRAS Candidates
Non-IND Development Pathway May Save Time And Money
Emerging Company Profile: Axcella uses Generally Recognized As Safe (GRAS) amino acids to create drug candidates for hepatic encephalopathy, NASH and other diseases.
